Science ❯ Biotechnology ❯ Drug Development

Clinical Research

FDA-Approved Drugs Seizure Medications Therapeutic Proteins Gene Therapy Cancer Treatment Phase 1 Trials Innovative Therapies Phase 3 Trials Innovations Midstage Trials

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

Investors weigh promising Phase 2b results against the need for Phase 3 confirmation and a cautious analyst outlook.

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

myTomorrows Raises $29 Million From Avego to Scale AI Platform for Pre-Approval Treatments

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research